If your issue is wanting (not performance), and especially if PDE5 inhibitors haven't solved the problem, PT-141 is worth discussing with your provider
However, results from phase 2 studies, early phase 3 readouts, meta-analyses and body-composition sub-studies have attracted extraordinary attention
But its also what holds it back in effectiveness, especially compared to tirzepatide
David Mendosa, an early patient on Byetta, famously reported needing a grabber tool to pick up newspapers before, but after losing over 100 lbs on exenatide in a year, he was able to resume mountain hikes ( [103] ) ( [20] )
This is not like treating strep throat," Ashton said
Here's a breakdown of what's shifting: #SupplyChain #CPG #FoodAndBeverage #Innovation #Resilience #Leadership #GoToMarket To view or add a comment, sign in (Gift link) Good article for any industry